ARCHIVES

FDA Committee IK IL-2/LAK For Modified Group C

This article is from The Cancer Letter archive.

Vol. 13 No. 18 | May 1, 1987

Download PDF Visit The Full Archive

Related Articles

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975

A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies

October 2, 2009

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008

Study: Gene Assay Can Provide Valid Prognostic Information

January 31, 2014

In Brief: Ford To Go Along With Cooper As Health Chief, Fredrickson As NIH Director, W.H. Sources Says

March 14, 1975

Copeland Named Director, UF Cancer Center

February 10, 1995